Combining C reactive protein and serum albumin to predict 90-day mortality in systemic lupus erythematosus with serious community-acquired infections

by Jun Ma, Jie Yu, Wei Zhou, Yi Chen, Chao Tang, Xingyu Zhang, Shuangjun He, Minjie Qiao
Published 2021-07-01

A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus

by John Conklin, Vinicius Domingues, Roberta Vezza Alexander, Arthur Weinstein, Mansoor Ahmed, Daniel Scott Rey, Jazibeh Qureshi
Published 2021-07-01

LUPUS-BEST—treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial

by Matthias Schneider, Ralph Brinks, Johanna Mucke, Oliver Kuss, Sabine Schanze
Published 2021-07-01

Peripheral neuropathy in systemic lupus erythematosus: what can neuromuscular ultrasonography (NMUS) tell us? A cross-sectional study

by Marco Matucci-Cerinic, Serena Guiducci, Felice Galluccio, Safaa A Mahran, Tayseer Mohamed Khedr, Amira Elsonbaty, Abdallah El-Sayed Allam, Alvaro Garcia Martos, Doaa M M Osman, Marwa A A Galal
Published 2021-07-01

Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR)

by Ian N Bruce, Eoghan M McCarthy, Ben Parker, Sarah Dyball, Sophie Collinson, Emily Sutton
Published 2021-07-01

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study

by Elisabet Svenungsson, Iva Gunnarsson, Agneta Zickert, Ioannis Parodis, Isak Samuelsson, Claes Hofman-Bang, Håkan Wallén
Published 2021-07-01

Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus

by Søren Jacobsen, Esben Laugesen, Jesper Fleischer, Henrik Christian Bidstrup Leffers, Amanda Hempel Zinglersen, Katrine Kjær Iversen
Published 2021-07-01

Programme

by Andrea Doria, Annegret Kuhn, Marzia Caproni
Published 2020-09-01

CS-31 Safety of hydroxychloroquine withdrawal in older adults with systemic lupus erythematosus

by Anca Askanase, Peter Izmirly, Nicole Bornkamp, Jill P Buyon, Michael D Lockshin, Anna Zezon, Chung-E Tseng, H Michael Belmont, Jane E Salmon
Published 2018-08-01

18 Rare disease manifestations in SLE

by Richard Furie, Zahir Amoura, David Isenberg
Published 2020-09-01

Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review

by Vibeke Strand, Zahi Touma, Alexa Simon Meara, Lee S Simon
Published 2020-12-01

Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus

by Benjamin A Nanes, Jane L Zhu, Benjamin F Chong
Published 2020-12-01

Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus

by Laurence S Magder, Michelle A Petri, Mertcan Avci
Published 2020-12-01

Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-control...

by Anca D Askanase, Enxu Zhao, Julie Zhu, Erin Connolly-Strong
Published 2020-12-01

Learning to listen: how empathetic engagement with patients can help overcome reproductive injustice

by Megan E B Clowse
Published 2020-12-01

Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower...

by Thomas Gustafsson, Sofia Ajeganova, Linnea Lindberg, Ingiäld Hafström, Johan Frostegård
Published 2020-12-01

Serum uric acid is associated with damage in patients with systemic lupus erythematosus

by Risto Alfredo Perich-Campos, Claudia Elera-Fitzcarrald, Cristina Reátegui-Sokolova, Rocio Violeta Gamboa-Cardenas, Mariela Medina, Francisco Zevallos, Victor Román Pimentel-Quiroz, Jorge Mariano Cucho-Venegas, José Alfaro-Lozano, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza
Published 2020-12-01

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease

by Myrto Kostopoulou, Aggelos Banos, Sofia Flouda, Pelagia Katsimbri, John Boletis, Dionysis S Nikolopoulos, Antigoni Pieta, Katerina Chavatza
Published 2020-12-01

Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE

by Ola Nived, Andreas Jönsen, Anna Jöud, Helena Tydén, Anders A Bengtsson
Published 2020-12-01

Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis

by Karen H Costenbader, Jianmin Wu, Julie A Birt, Kirstin Griffing, Natalia Bello, Nicole Princic, Isabelle Winer, Carolyn R Lew
Published 2020-12-01